NGL Fine-Chem Limited has scheduled its 45th Annual General Meeting (AGM) for Tuesday, August 25, 2026, to be conducted exclusively through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The meeting aims to transact the business outlined in the notice, with shareholders able to participate remotely without physical presence at a common venue. This virtual format ensures broader accessibility for members while adhering to regulatory compliance standards.

The company dispatched the notice for the 45th AGM along with the Annual Report for the Financial Year 2025-26 on Friday, July 31, 2026, to all members who have registered their email addresses with the Company, Registrar and Share Transfer Agent (RTA), or Depository Participants. In compliance with Regulation 36(1)(b) of the SEBI Listing Regulations, a letter containing web-links to access these documents was also sent to members who have not registered their email addresses. The documents are available on the company’s website, stock exchange portals, and the RTA’s platform.

Shareholders are provided the facility to vote on resolutions through remote e-voting as well as during the AGM. The remote e-voting period commences at 9:00 A.M. (IST) on Saturday, August 22, 2026, and concludes at 5:00 P.M. (IST) on Monday, August 24, 2026. After this deadline, the e-voting module will be disabled. Members whose names appear in the Register of Members or the Register of Beneficial Owners maintained by the Depositories as on the cut-off date of Tuesday, August 18, 2026, are eligible to vote.

To facilitate smooth participation, the Register of Members and Share Transfer Books will remain closed from Wednesday, August 19, 2026, to Tuesday, August 25, 2026 (both days inclusive). This closure is necessary for the purpose of conducting the AGM and for the payment of dividends, if declared. Members are advised to update their email addresses with their respective Depository Participants or the RTA, Purva Sharegistry (India) Private Limited, to receive electronic communications and ensure seamless access to e-voting facilities.

Key Dates and Timelines

Members who have already cast their votes through remote e-voting may attend the AGM via VC/OAVM but will not be entitled to vote again during the meeting. Conversely, those who have not voted remotely can exercise their voting rights through the e-voting system available during the AGM. For any queries regarding e-voting, shareholders may contact Purva Sharegistry (India) Private Limited at evoting@purvashare.com .

NGL Fine-Chem Limited reported a consolidated net profit of ₹48.13 crore for FY26, marking a 128% year-on-year increase from ₹21.12 crore in FY25. The pharmaceutical manufacturer achieved this growth on the back of a 36% rise in revenue from operations to ₹500.95 crore, supported by volume-led recovery across key markets including Latin America and Europe. Shareholders will vote on these results and a recommended final dividend of ₹1.75 per equity share at the 45th Annual General Meeting scheduled for August 25, 2026.

The company’s operational performance strengthened significantly during the year, with EBITDA more than doubling to ₹72.69 crore, reflecting an improved margin of 14.51% compared to 9.2% in the previous year. This profitability expansion was driven by higher capacity utilization, improved manufacturing efficiencies, and stronger cost absorption. Total income rose to ₹515.68 crore, while profit before tax increased by approximately 129% to ₹63.37 crore. Finance costs stood at ₹4.47 crore and depreciation at ₹19.58 crore, reflecting the larger asset base following recent investments.

Financial Performance and Operational Recovery

The recovery in financial metrics was consistent throughout FY26, with more pronounced improvements in the second half due to sustained volume growth. While elevated freight costs and currency volatility posed headwinds, the company secured partial price pass-throughs towards the end of the year. The balance sheet remained robust, with shareholders’ funds increasing to ₹329.23 crore. Total borrowings rose to ₹108.42 crore to fund expansion programs, maintaining a prudent debt-equity ratio of 0.33. Cash flow from operating activities was ₹43.32 crore, offsetting ₹70.59 crore used in investing activities primarily for the Tarapur greenfield project.

*Note: FY25 EBITDA derived from margin application for context; source states EBITDA more than doubled.

Corporate Governance and Dividend Proposal

The Board of Directors, meeting on May 21, 2026, recommended a final dividend of ₹1.75 per fully paid-up equity share, aggregating to ₹108.12 lakh. This dividend is subject to shareholder approval at the AGM. The record date for dividend entitlement is August 18, 2026, with the register of members closed from August 19 to August 25, 2026. The AGM will be conducted via Video Conferencing (VC) or Other Audio-Visual Means (OAVM), allowing remote participation and e-voting through Purva Sharegistry (India) Private Limited.

Strategic Outlook and Expansion

NGL Fine-Chem continues to strengthen its position in the veterinary API segment, serving over 430 customers across 55 countries. The company’s ongoing capital expenditure program, particularly the greenfield expansion at Tarapur, is targeted for commissioning in Q2FY27. Management expects commercial production from new facilities to begin in the second half of the following financial year, supporting future growth. With a diversified product portfolio and advancing regulatory pipeline, including CEP approvals and US FDA registrations, the company is positioned to capitalize on the structural shift in global sourcing towards India.

What the Numbers Show

The divergence between revenue growth (36%) and net profit growth (128%) highlights significant operating leverage achieved by NGL Fine-Chem in FY26. The nearly 530 basis point expansion in EBITDA margins indicates that volume growth was not merely offset by input costs but actively converted into higher profitability through efficiency gains. This suggests that the company’s backward integration and process chemistry expertise are yielding tangible financial benefits, reducing reliance on pure volume scaling for profit generation.